TG Therapeutics Inc. Stock
TG Therapeutics Inc. Stock
There is an upward development for TG Therapeutics Inc. compared to yesterday, with an increase of €0.90 (2.090%).
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 55 € shows a positive potential of 27.61% compared to the current price of 43.1 € for TG Therapeutics Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for TG Therapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of TG Therapeutics Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of TG Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| TG Therapeutics Inc. | 2.090% | -4.435% | -15.157% | 80.146% | 65.801% | 370.216% | 115.177% |
| Evolus Inc | 2.620% | 5.140% | -10.131% | 4.419% | 0.587% | -38.404% | -43.485% |
| Heron Therapeutics Inc. | -2.600% | -2.739% | 12.453% | -73.548% | -62.388% | -72.792% | -95.833% |
| Rhythm Pharmaceuticals | -1.050% | 3.279% | -1.563% | 24.342% | 1.070% | 333.486% | 707.692% |
Comments
TG Therapeutics (TGTX) had its price target raised by JPMorgan Chase & Co. from $65.00 to $72.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (TGTX) had its "buy" rating reaffirmed by B. Riley Financial, Inc..
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (TGTX) had its price target raised by HC Wainwright from $70.00 to $77.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat